Bone disease in primary hypercalciuria

Critical Reviews in Clinical Laboratory Sciences

Volumn 42, Issue 3, 2005, Pages 229-248

  Giannini, Sandro ^a,b   Nobile, Martino ^a   Sella, Stefania ^a   Dalle Carbonare, Luca ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Bone density; Bone histomorphometry; Bone loss; Bone resorbing cytokines; Intestinal calcium absorption; Osteoporosis; Phosphate metabolism; Secondary hypercalciuria; Thiazides; Urine calcium excretion

Indexed keywords

ACID; BIOLOGICAL MARKER; CALCIUM; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

BONE DEMINERALIZATION; BONE DENSITY; BONE DISEASE; BONE METABOLISM; BONE TISSUE; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM EXCRETION; CALCIUM INTAKE; CALCIUM TRANSPORT; DISEASE CLASSIFICATION; FRAGILITY FRACTURE; HUMAN; HYPERCALCIURIA; HYPOPHOSPHATEMIA; INTESTINE; INTESTINE ABSORPTION; KIDNEY; KIDNEY TUBULE ABSORPTION; LABORATORY TEST; MORPHOMETRICS; NEPHROLITHIASIS; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PHOSPHATE URINE LEVEL; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; RICKETS; SECONDARY HYPERPARATHYROIDISM; VITAMIN D RESISTANT RICKETS; ANIMAL; ELECTROLYTE DISTURBANCE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; BONE DISEASES; CALCIUM METABOLISM DISORDERS; CALCIUM, DIETARY; HUMANS;

EID: 26944496506     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408360590913533     Document Type: Review

References (75)

1. Albright F, Henneman P, Benedict PH, Forbes AP. Idiopathic hypercalciuria: a preliminary report. Proc R Soc Med 1953; 46: 1077-1081.
2. Hodgkinson A, Pyrah LN. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg 1958; 46: 10-18.
3. Smith LH, VanDenBerg Cj, Wilson DM. Nutrition and urolithiasis. N Engl J Med 1980; 98: 87-89.
4. Pak CY. Medical management of nephrolithiasis. J Urol 1982; 128: 1157-1164.
5. Pak CY, Ohata M, Lawrence EC, Synder W. The hypercalciurias: causes, parathyroid functions, and diagnostic criteria. J Clin Invest 1974; 54: 387-400.
6. Heaney RP, Recker RR, Ryan RA. Urinary calcium in perimenopausal women: normative values. Osteoporos Int 1999; 9: 13-18.
7. Kerstetter JE, O'Brian KO, Insogna KL. Low protein intake: the impact on calcium and bone homeostasis in humans. J Nutr 2003; 133: 855S-861S.
8. Nordin BE, Need AG, Morris HA, Horowitz M. The nature and significance of the relationship between urinary sodium and urinary calcium in women. J Nutr 1993; 123: 1615-1622.
9. Hegsted M, Schuette SA, Zemel MB, Linkswiler HM. Urinary calcium and calcium balance in young men as affected by level of protein and phosphorus intake. J Nutr 1981; 111: 553-562.
10. Zemel MB. Calcium utilization: effect of varying level and source of dietary protein. Am J Clin Nutr 1988; 48: 880-883.
11. Kerstetter JE, O'Brien KO, Insogna KL. Dietary protein, calcium metabolism, and skeletal homeostasis revisited. Am J Clin Nutr 2003; 78: 584S-592S.
12. Pak CY, Britton F, Peterson R, Ward D, Northcott C, Breslau N, MacGuire J, Nicar M, Norman DA, Peters P. Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med 1980; 69: 19-30.
13. Vezzoli G, Tanini A, Ferrucci L, Soldati L, Bianchin C, Franceschelli F, Malentacchi C, Porfirio B, Adamo D, Terranegra A, Falchetti A, Cusi D, Blanchi G, Brandi ML. Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol 2002; 13: 2517-2523.
14. Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer BE. Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 1984; 311: 73-80.
15. Li XQ, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ. Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption. J Clin Invest 1993; 91: 661-667.
16. Zerwekh JE, Reed BY, Heller HJ, Gonzalez GB, Haussler MR, Pak CY. Normal vitamin D receptor concentration and responsiveness to 1, 25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner Electrolyte Metab 1998; 24: 307-313.
17. Prié D, Ravery V, Boccon-Gibod L, Friedlander G. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int 2001; 60: 272-276.
18. Bushinsky DA. Genetic hypercalciuric stone-forming rats. Curr Opin Nephrol Hypertens 1999; 8: 479-88.
19. Bataille P, Fardellone P, Ghazali A, Cayrolle G, Hottelart C, Achard JM, Fournier A. Pathophysiology and treatment of idiopathic hypercalciuria. Curr Opin Rheumatol 1998; 10: 373-388.
20. Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1998; 98: 50-59.
21. Weisinger JR. New insights in the pathogenesis of idiopathic hypercalciuria; the role of bone. Kidney Int 1996; 49: 1507-1518.
22. Lawoyin S, Sismilich S, Browne R, Pak CY. Bone mineral content in patients with calcium urolithiasis. Metabolism 1979; 28: 1250-1254.
23. Fuss M, Gillet C, Simon J, Vandewalle JC, Schoutens A, Bergmann P. Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism. Eur Urol 1983; 9: 32-34.
24. Pacifici R, Rothstein M, Rifas L, Lau KH, Baylink DJ, Avioli LV, Hruska K. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 1990; 71: 138-145.
25. Bataille P, Achard JM, Fournier A, Boudailliez B, Westeel PF, El Esper N, Bergot C, Jans I, Lalau JD, Petit J, Henon G, Laval Jeantet MA, Bouillon R, Sebert JL. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 1991; 39: 1193-1205.
26. Borghi L, Meschi T, Guerra A, Maninetti L, Pedrazzoni M, Marcato A, Vescovi P, Novarini A. Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol 1991; 146: 1334-1338.
27. Pietschmann F, Breslau NA, Pak CY. Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 1992; 7: 1383-1388.
28. Jaeger P, Lippuner K, Casez JP, Hess B, Ackermann D, Hug C. Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 1994; 9: 1525-1532.
29. Weisinger JR, Alonzo E, Bellorin-Font E, Blasini AM, Rodriguez MA, Paz-Martinez V, Martinis R. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 1996; 49: 244-250.
30. Ghazali A, Fuentes V, Desaint C, Bataille P, Westeel A, Brazier M, Prin L, Fournier A. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 1997; 82: 32-38.
31. Giannini S, Nobile M, Sartori L, Calò L, Tasca A, Dalle Carbonare L, Ciuffreda M, D'Angelo A, Pagano F, Crepaldi G. Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clinical Nephrology 1998; 50: 94-100.
32. Misael da Silva AM, dos Reis LM, Pereira RC, Futata E, Branco-Martins CT, Noronha IL, Wajchemberg BL, Jorgetti V. Bone involvement in idiopathic hypercalciuria. Clin Nephrol 2002; 57: 183-191.
33. Tasca A, Cacciola A, Ferrarese P, Ioverno E, Visona E, Bernardi C, Nobile M, Giannini S. Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urology 2002; 59: 865-869.
34. Asplin JR, Bauer KA, Kinder J, Muller G, Coe BJ, Parks JH, Coe FL. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int 2003; 63: 662-669.
35. Vezzoli G, Rubinacci A, Bianchin C, Arcidiacono T, Giambona S, Mignogna G, Fochesato E, Terranegra A, Cusi D, Soldati L. Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria. Am J Kidney Dis 2003; 42: 1177-1183.
36. Caudarella R, Vescini F, Buffa A. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 2003; 16: 260-266.
37. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994; 4: 368-381.
38. Melton LJ III, Crowson CS, Khosla S, Wilson DM, O'Fallon WM. Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 1998; 53: 459-464.
39. Lauderdale DS, Thisted RA, Wen M, Favus MJ. Bone mineral Density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 2001; 16: 1893-1898.
40. Heilberg IP, Martini LA, Szejnfeld VL. Bone disease in calcium stone forming patients. Clin Nephrol 1994; 42: 175-182.
41. Bordier P, Rychewart A, Gueris J, Rasmussen H. On the pathogenesis of so-called idiopathic hypercalciuria. Am J Med 1977; 63: 398-409.
42. Steiniche T, Mosekilde L, Christensen MS, Meisen F. A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. Acta Pathol Microbiol Immunol Scand 1989; 97: 309-316.
43. Malluche HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry SG. Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 1980; 50: 654-658.
44. Thomas J, Roujean J, Aboulker P. Les lésions osseuses dans la lithiase rénale. Leur étude par examen histologique d'un fragment costal. Presse Med 1962; 70: 2437-2440.
45. Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY. Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos Int 1992; 2: 128-134.
46. Satton RAL, Walker VR. Bone resorption and hypercalciuria in calcium stone formers. Metabolism 1986; 35: 485-488.
47. Barkin J, Wilson DR, Manuel MA, Bayley A, Murray T, Harrison J. Bone mineral content in idiopathic calcium nephrolithiasis. Miner Electrolyte Metab 1985; 11: 19-24.
48. Feskanich D, Willett WC, Stampfer MJ, Colditz GA. A prospective study of thiazide use and fractures in women. Osteoporos Int 1997; 7: 79-84.
49. LaCroix AZ, Wienpahl J, White LR, Wallace RB, Scherr PA, George LK, Cornoni-Huntley J, Ostfeld AM. Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med 1990; 322: 286-290.
50. Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 1996; 144: 255-263.
51. Cauley JA, Cummings SR, Seeley DG, Black D, Browner W, Kuller LH, Nevitt MC. Effects of thiazide diuretic therapy on bone mass, fractures and falls. The Study of Osteoporotic Fractures Research Group. Ann Intern Med 1993; 118: 666-673.
52. Felson DT, Sloutskis D, Anderson JJ, Anthony JM, Kiel DP. Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study. JAMA 1991; 265: 370-373.
53. Schoofs MWJC, van der Klift M, Hofman A, de Laet CE, Herings RM, Stijnen T, Pols H.A., Snicker BH. Thiazide diuretics and the risk for hip fracture. Ann Intern Med 2003; 139: 476-482.
54. Adams JS, Song CF, Kantorovich V. Rapid recovery of bone mass in hypercalciuric, osteoporotic man treated with hydrochlorothiazide. Ann Intern Med 1999; 130: 658-660.
55. Reid IR, Ames RW, Orr-Walker BJ, Clearwater JM, Horne AM, Evans MC, Murray MA, McNeil AR, Gamble GD. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial. Am J Med 2000; 109: 362-370.
56. LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE. Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 133: 516-526.
57. Gowen M, Mundy GR. Actions of recombinant interleukin 1, interleukin 2 and interferon-gamma on bone resorption in vitro. J Immunol 1986; 136: 2478-2482.
58. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000; 21: 115-137.
59. Cohen-Solal ME, Graulet AM, Gueris J, Denne MA, Bergot C, Morieux C, Sedel L, Kuntz D, De Vernejoul MC. Bone resorption at the femoral neck is dependent on local factors in non osteoporotic late postmenopausal women: an in vivo-in vitro study. J Bone Miner Res 1995; 10: 307-315.
60. Chen WC, Wu HC, Chen HY, Wu MC, Hsu CD, Tsai FJ. Interleukin-1beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones. Urol Res 2001; 29: 321-324.
61. Giannini S, Nobile M, Sartori L, Dalle Carbonare L, Ciuffreda M, Corrò P, D'Angelo A, CaIo L, Crepaldi G. Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr 1999; 9: 267-271.
62. Maierhofer WJ, Gray RW, Cheung HS, Lemann JJr. Bone resorption stimulated by elevated serum 1,25 (OH)2-vitamin D concentrations in healthy men. Kidney Int 1983; 24: 555-560.
63. Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 2003; 14: 1082-1095.
64. Fuss M, Pepersack T, Bergman P, Hurard T, Simon J, Corvilain J. Low calcium diet in idiopathic urolithiasis: a risk factor for osteopenia as great as in primary hyperparathyroidism. Br J Urol 1990; 65: 560-563.
65. Hess B. Low calcium diet in hypercalciuric calcium nephrolithiasis: first do not harm. Scanning Microsc 1996; 10: 547-554.
66. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993; 328: 833-838.
67. Williams CP, Child DF, Hudson PR, Soysa LD, Davies GK, Davies MG, De Bolla AR. Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatment? J Clin Pathol 1996; 49: 881-888.
68. Prié D, Ravery V, Boccon-Gibod L, Friedlander G. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int 2001; 60: 272-276.
69. Tieder M, Modai D, Shaked U, Samuel R, Arie R, Halabe A, Maor J, Weissgarten J, Averbukh Z, Cohen N, Edelstein S, Liberman UA. "Idiopathic" hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect. N Engl J Med 1987; 316: 125-129.
70. Prié D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp B, Friedlander G. Nephrolithiasis and osteoporosis associated with hypophos-phatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 2002; 347: 983-991.
71. Tannenbaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D, Luckey M. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 2002; 87: 4431-4437.
72. Deutschmann HA, Weger M, Weger W, Kotanko P, Deutschmann MJ, Skrabal F. Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density. J Intern Med 2002; 252: 389-397.
73. Peris P, Guanabens N, Martinez de Osaba MJ, Monegal A, Alvarez L, Pons F, Ros I, Gerda D, Munoz-Gomez J. Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum 2002; 32: 64-70.
74. Giannini S, Nobile M, Dalle Carbonare L, Lodetti MG, Sella S, Vittadello G, Minicuci N, Crepaldi G. Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. Eur J Endocrinol 2003; 149: 209-213.
75. Heshmati HM, Khosla S, Burritt MF, O'Fallon WM, Riggs BL. A defect in renal calcium conservation may contribute to the pathogenesis of postmenopausal osteoporosis. J Clin Endocrinol Metab 1998; 83: 1916-1920.